⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2030154 | 1.00 | — | — | |
| SCHEMBL23170 | 1.00 | — | — | |
| SCHEMBL29818313 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL16798191 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL202670 | 0.98 | — | — | |
| Formic Acid SCHEMBL6596895 | 0.91 | SLC1A2 (0.33) | — | |
| SCHEMBL5293023 | 0.86 | — | — | |
| Pipecolic Acid SCHEMBL8894672 | 0.83 | DPP4 (0.41) | — | |
| SCHEMBL23421623 | 0.82 | MAPT (0.32) | — | |
| SCHEMBL2532769 | 0.82 | MAPT (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3433 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091067-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MARVELBIOME INC (US) | 2026-04-02 | — | — | US | claimed |
| EP-4679087-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| US-20250361490-A1 | COMPOSITION AND METHOD FOR CRYOPRESERVATION OF MITOCHONDRIA | CELLVIE AG (CH) | 2025-11-27 | — | — | US | claimed |
| US-12428447-B2 | Peptide-based non-proteinaceous cargo delivery | FELDAN BIO INC. (CA) | 2025-09-30 | — | — | US | claimed |
| EP-4587116-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2025-07-23 | — | — | EP | claimed |
| EP-4535996-A1 | COMPOSITION AND METHOD FOR CRYOPRESERVATION OF MITOCHONDRIA | cellvie AG (CH) | 2025-04-16 | — | — | EP | claimed |
| WO-2025054048-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING LIPID AND CHOLESTEROL METABOLISM ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2025-03-13 | — | — | WO | claimed |
| WO-2025032025-A1 | STABLE GLASSY MATERIAL BASED ON HISTIDINE, ARGININE AND GLUTAMIC ACID AMINO ACIDS | VITROPEP (FR) | 2025-02-13 | — | — | WO | claimed |
| CN-119365073-A | Compositions and methods for cryopreserving mitochondria | 赛立维公司 | 2025-01-24 | — | — | CN | claimed |
| EP-4440342-A1 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING VAGUS NERVE ASSOCIATED DISEASES, DISORDERS, AND CONDITIONS | MarvelBiome, Inc. (US) | 2024-10-09 | — | — | EP | claimed |
| WO-2005112999-A2 | CANCER TREATMENT WITH INHIBITORS OF COLLAGEN SYNTHESIS | VECTRAMED, INC. (US) | 2005-12-01 | — | — | WO | claimed |
| US-20050118180-A1 | Inhibition of abnormal cell proliferation with camptothecin and combinations including the same | SUPERGEN, INC. | 2005-06-02 | — | — | US | claimed |
| EP-1276479-A2 | INHIBITION OF ABNORMAL CELL PROLIFERATION WITH CAMPTOTHECIN AND COMBINATIONS INCLUDING THE SAME | SuperGen, Inc. (US) | 2003-01-22 | — | — | EP | claimed |
| US-20020111362-A1 | Inhibition of abnormal cell proliferation with camptothecin and combinations including the same | SUPERGEN, INC. | 2002-08-15 | — | — | US | claimed |
| WO-2001080843-A2 | INHIBITION OF ABNORMAL CELL PROLIFERATION WITH CAMPTOTHECIN AND COMBINATIONS INCLUDING THE SAME | SUPERGEN, INC. (US) | 2001-11-01 | — | — | WO | claimed |
| US-6251249-B1 | IODIDE-FREE AND CONTAIN AN ORGANOSULFUR COMPOUND AND/OR A CARBOXYLIC ACID; PRECIOUS METAL ALKANESULFONATES, PRECIOUS METAL ALKANESULFONAMIDES AND/OR PRECIOUS METAL SOURCE | ATOFINA CHEMICALS, INC. | 2001-06-26 | — | — | US | claimed |
| EP-0672678-B1 | Azapeptide derivative | FUJIREBIO KK (JP) | 2000-10-25 | — | — | EP | claimed |
| US-5965538-A | FOR TREATING NERVOUS INFLAMMATION OF RESPIRATORY SYSTEMS, ASTHMA, BRONCHOSPASM | FUJIREBIO INC. (JP) | 1999-10-12 | — | — | US | claimed |
| US-5770574-A | Long-chain alkylamides of amino acids and peptides with anti-proliferative and anti-inflammatory properties | ASTA MEDICA AKTIENGESELLSCHAFT (DE) | 1998-06-23 | — | — | US | claimed |
| EP-0672678-A1 | Azapeptide derivative | FUJIREBIO Inc. (JP) | 1995-09-20 | — | — | EP | claimed |